I believe they already have a buyer. This is why GC is so confident about no need for a R/S. I believe the deal will be disclosed when Icon testing is 100% complete. the results will be verified as the new gold standard. I think his reference in the CC last summer to the story of the current( #1) test being used, and how it was purchased for over eight-hundred million and isn't as accurate as Lympro, and is much more expensive, was our clue.
Lympro will be sold, we will uplist and we will leave penny lane. But not till the results are in.
IMHO
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links